Health
ONO PHARMA USA Announces Support for Conquer Cancer®, the ASCO Foundation
Conquer Cancer Supports Cancer Research and Education CAMBRIDGE, Mass., June 25, 2024 /PRNewswire/ -- ONO PHARMA USA today announced it will provide a sponsorship to Conquer Cancer®, the ASCO Foundation, with$1 million funding to advance cancer research and education. Conquer Cancer is a glob...
2024-06-25 21:00
1153
Endogenex™ Announces $88 Million Series C Financing to Complete Pivotal Trial of the ReCET™ System in Patients with Type 2 Diabetes
Oversubscribed financing led by strategic investor, with participation from new and existing investors MINNEAPOLIS, June 25, 2024 /PRNewswire/ -- Endogenex, a clinical-stage medical device company dedicated to improving outcomes in individuals with type 2 diabetes, announced it has closed an ove...
2024-06-25 20:22
1546
Porton Advanced introduces the MaxCyte ExPERT GTx Flow Electroporation instrument, continuing to provide customers with end-to-end cell and gene therapy CRO & CDMO services
SUZHOU, China, June 25, 2024 /PRNewswire/ -- Porton Advanced recently introduced the MaxCyte cGMP-grade ExPERT GTx Flow Electroporation instrument to its cell therapy platform, marking the company as the first cell therapy CDMO in China to possess this clinical-grade flow electroporation system. T...
2024-06-25 20:00
2000
Metabolon Receives NIH Grant to Develop Advanced Monitoring and Predictive Tools for Type 1 Diabetes Progression
MORRISVILLE, N.C., June 25, 2024 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic development, and precision medicine applications, is proud to announce the receipt of a prestigious gr...
2024-06-25 19:57
1304
CLL Community Urges Hospital Authority to List Next-Generation BTK Inhibitor on Drug Formulary to Bring Hope and Improve Quality of Life for CLL Patients
HONG KONG, June 25, 2024 /PRNewswire/ -- Chronic Lymphocytic Leukaemia ('CLL') is a lymphoproliferative disease characterised by the abnormal proliferation of lymphocytes. The progression of CLL is relatively slow and it is a mild haematological malignancy. Cypress Charitable Trust is aHong Kong ...
2024-06-25 17:00
1914
NX Group Signs Strategic Partnership Agreement with Controlant of Iceland
- Set to Provide Real-time Monitoring Service for Tracking Cargo Location and Strict Temperature Control - TOKYO, June 25, 2024 /PRNewswire/ -- NIPPON EXPRESS HOLDINGS, INC. has signed a strategic partnership agreement withIceland-based Controlant, Inc., a leading provider of real-time monitorin...
2024-06-25 14:00
1442
IBISA raises $3 million to scale parametric insurance solutions, strengthening climate resilience across Asia and Africa.
LUXEMBOURG, June 25, 2024 /PRNewswire/ -- IBISA
2024-06-25 13:00
1865
Singclean: Unveiled Singfiller® and Singderm® in IMCAS ASIA 2024, Poised for Thailand's Big Launch
BANGKOK, June 25, 2024 /PRNewswire/ -- Singclean, a global player and a leading Chinese manufacturer of high-quality medical aesthetic products, was excited to announce in IMCAS Asia that Singfiller® and Singderm® HA fillers will launch in Thailand this November. Although still not officially cer...
2024-06-25 11:00
2184
Innovent Presents the Results of the First Phase 3 Study of Mazdutide for Weight Management at the ADA's 84th Scientific Sessions
SAN FRANCISCO and SUZHOU, China, June 25, 2024 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ...
2024-06-25 08:17
2199
Innovent Announces Mazdutide Demonstrates 80.2% Reduction in Liver Fat Content in Exploratory Analysis of Phase 3 Weight Management GLORY-1 Study at ADA 2024
SAN FRANCISCO and SUZHOU, China, June 25, 2024 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ...
2024-06-25 08:00
2358
NABR Commends the IUCN's Decision to Reassess the Status of Long-Tailed Macaques
A Science-Based Approach Will Determine if the Species is Truly 'Endangered' WASHINGTON, June 25, 2024 /PRNewswire/ -- The National Association for Biomedical Research (NABR) commends the Union for the Conservation of Nature (IUCN)'s decision to reassess the 'Endangered' designation of long-taile...
2024-06-25 05:32
1737
Science and Technology Daily: China's Fertile Grounds for Innovation
BEIJING, June 24, 2024 /PRNewswire/ -- On June 24, ten experts received the China International Science and Technology Cooperation Award at the National Science and Technology Award Conference inBeijing. Science and Technology Daily: China's Fertile Grounds for Innovation They stand as eminen...
2024-06-24 21:41
2250
Bota Bio's Biomanufacturing Technology is Commercialized at NHU with A Successful Strategic Partnership Established
Bota's end-to-end bio-foundry tackles the challenge of transitioning from lab-developed technology to industrial-scale production, and empowers the rapid and efficient translation of cutting-edge biotechnology into tangible commercial value. SAN FRANCISCO, HANGZHOU and XINCHANG, China, June 24, ...
2024-06-24 21:00
1739
iRegene Receives IND approval from U.S. FDA to Start Clinical Trial for Parkinson's Disease
WUHAN, China, June 24, 2024 /PRNewswire/ -- On June 20 (UTC-4), the U.S. Food and Drug Administration (FDA) approved the IND application for NouvNeu001, a cell therapy product from iRegene therapeutics targeting Parkinson's Disease. This marks a significant milestone as NouvNeu001 becomes the wor...
2024-06-24 20:00
1564
TiumBio Presents Promising Clinical Data from Phase 1 of its Hemophilia Treatment Candidate TU7710 at ISTH 2024
* TU7710, long-acting recombinant activated factor VII, demonstrated a 5 to 7 times longer half-lifein a Phase 1 study than that of NovoSeven, a conventional hemophilia treatment for patients who develop inhibitors * TiumBio presented interim Phase 1a clinical data of TU7710 and discussed pot...
2024-06-24 20:00
1785
Wingderm® Shines at IMCAS Asia 2024 with the Innovative Aesthetic Solutions
BEIJING, June 24, 2024 /PRNewswire/ -- From June 21 to 23, IMCAS Asia was held
inBangkok, Thailand. Wingderm®, a provider of medical aesthetic devices, has
garnered significant attention with its innovative aesthetic solutions.
2024-06-24 12:31
1664
AXA Celebrates Record-Breaking 10 Industry Wins at Bloomberg Businessweek Financial Institutions Awards 2024
HONG KONG, June 24, 2024 /PRNewswire/ -- AXA Hong Kong and Macau ("AXA") set a record at the Bloomberg Businessweek Financial Institutions Awards 2024, winning a total of ten prestigious awards. This remarkable achievement includes six Excellence awards and four Outstanding awards, covering vario...
2024-06-24 12:08
1977
Juniper Biologics Expands Distribution Rights for Caris Life Sciences' Molecular Profiling in the Middle East and Africa
SINGAPORE, June 24, 2024 /PRNewswire/ -- Singapore-headquartered Juniper Biologics Pte Ltd (Juniper), a leading healthcare and pharmaceuticals company focused on commercialising novel therapies, has been granted distribution rights for Caris Life Sciences (Caris)' solid tumour molecular profiling...
2024-06-24 09:00
1776
Ascentage Pharma Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering of American Depositary Shares
ROCKVILLE, Md. and SUZHOU, China, June 24, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK) announced that it has confidentially submitted a draft registration statement on Form F-1 to the U.S. Securities and Exchange Commission (the "SEC") relating to the proposed initial public offering of Amer...
2024-06-24 08:15
3130
Gan & Lee Pharmaceuticals Announces Significant Progress on New Diabetes and Obesity Treatments at the American Diabetes Association's 84th Scientific Sessions
BEIJING and BRIDGEWATER, N.J., June 23, 2024 /PRNewswire/ -- Gan & Lee Pharmaceuticals (Gan & Lee, Shanghai Stock Exchange: 603087) announced the results of the Phase1b/2a clinical study of the Company's independently developed glucagon-like peptide-1 (GLP-1) receptor agonist, GZR18 Injection, in...
2024-06-23 21:09
2972
Week's Top Stories
Most Reposted
Mastercard goes OTP-free in APAC for faster, safer online transactions
[Picked up by 326 media titles]
2024-11-06 09:00Brankas Launches Integrated APAC Open Banking Compliance Solution with ADVANCE.AI's eKYC Solution
[Picked up by 319 media titles]
2024-11-07 09:00
Going Global: DCITS Embarks on International Expansion at Singapore Fintech Festival
[Picked up by 309 media titles]
2024-11-12 09:00
Ubiqconn Technology to Showcase Latest Marine Solutions at the 2024 International WorkBoat Show in New Orleans
[Picked up by 289 media titles]
2024-11-11 21:00
Sobot Introduces its All-in-One Solution at GITEX Global 2024
[Picked up by 284 media titles]
2024-11-12 11:00
Most Read
Mastercard goes OTP-free in APAC for faster, safer online transactions
2024-11-06 09:00
13117
Brankas Launches Integrated APAC Open Banking Compliance Solution with ADVANCE.AI's eKYC Solution
2024-11-07 09:00
10117
XtalPi and Sinar Mas Multiartha Launch Strategic Partnership to Revolutionize AI Across Asia-Pacific
2024-11-07 11:34
7458
XTEP's First Mono Store in Malaysia Comes to Puchong
2024-11-07 10:08
6173
